Literature DB >> 20890621

Regulation of Tcf7 by Runx2 in chondrocyte maturation and proliferation.

Masaki Mikasa1, Satoshi Rokutanda, Hisato Komori, Kosei Ito, Ying Sze Tsang, Yuki Date, Carolina A Yoshida, Toshihisa Komori.   

Abstract

Runx2 plays important roles in the regulation of chondrocyte differentiation and proliferation; however, the Runx2 target molecules still remain to be investigated. We searched the genes upregulated by the introduction of Runx2 into Runx2(-/-) chondrocytes using microarray and found that Tcf7 is upregulated by Runx2. Thus, we examined the functions of Runx2 in the regulation of the Tcf/Lef family of transcription factors. Runx2 induced Tcf7 and Lef1 strongly, but Tcf7l1 and Tcf7l2 only slightly in Runx2(-/-) chondrocytes; the expressions of Tcf7 and Tcf7l2 were reduced in Runx2(-/-) cartilaginous skeletons and calvaria, and Tcf7 showed a similar expression pattern to Runx2. In reporter assays, Runx2 mildly activated the 8.6 and 1.8 kb Tcf7 promoter constructs. The reporter assays using the deletion constructs of the 1.8-kb fragment showed that the 0.3-kb promoter region is responsible for the Runx2-dependent transcriptional activation. To investigate the function of Tcf7 in skeletal development, we generated dominant-negative (dn) Tcf7 transgenic mice using the Col2a1 promoter. Dn-Tcf7 transgenic embryos showed dwarfism, and mineralization was retarded in limbs, ribs, and vertebrae in a manner dependent on the expression levels of the transgene. In situ hybridization analysis showed that endochondral ossification is retarded in dn-Tcf7 transgenic embryos due to the decelerated chondrocyte maturation. Further, BrdU labeling showed a reduction in chondrocyte proliferation in the proliferating layer of the growth plate in dn-Tcf7 transgenic embryos. These findings indicate that Runx2 regulates chondrocyte maturation and proliferation at least partly through the induction of Tcf7.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890621     DOI: 10.1007/s00774-010-0222-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  26 in total

1.  Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog.

Authors:  Carolina A Yoshida; Hiromitsu Yamamoto; Takashi Fujita; Tatsuya Furuichi; Kosei Ito; Ken-ichi Inoue; Kei Yamana; Akira Zanma; Kenji Takada; Yoshiaki Ito; Toshihisa Komori
Journal:  Genes Dev       Date:  2004-04-15       Impact factor: 11.361

2.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Authors:  Donald A Glass; Peter Bialek; Jong Deok Ahn; Michael Starbuck; Millan S Patel; Hans Clevers; Mark M Taketo; Fanxin Long; Andrew P McMahon; Richard A Lang; Gerard Karsenty
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

Review 3.  Regulation of osteoblast differentiation by transcription factors.

Authors:  Toshihisa Komori
Journal:  J Cell Biochem       Date:  2006-12-01       Impact factor: 4.429

4.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Cbfa1 is a positive regulatory factor in chondrocyte maturation.

Authors:  H Enomoto; M Enomoto-Iwamoto; M Iwamoto; S Nomura; M Himeno; Y Kitamura; T Kishimoto; T Komori
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

6.  Regulation of chondrocyte differentiation by Cbfa1.

Authors:  I S Kim; F Otto; B Zabel; S Mundlos
Journal:  Mech Dev       Date:  1999-02       Impact factor: 1.882

7.  A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia.

Authors:  Y W Zhang; N Yasui; K Ito; G Huang; M Fujii; J Hanai; H Nogami; T Ochi; K Miyazono; Y Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

8.  Akt regulates skeletal development through GSK3, mTOR, and FoxOs.

Authors:  Satoshi Rokutanda; Takashi Fujita; Naoko Kanatani; Carolina A Yoshida; Hisato Komori; Wenguang Liu; Akio Mizuno; Toshihisa Komori
Journal:  Dev Biol       Date:  2009-01-14       Impact factor: 3.582

9.  Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.

Authors:  Hirayuki Enomoto; Satoko Shiojiri; Kazuto Hoshi; Tatsuya Furuichi; Ryo Fukuyama; Carolina A Yoshida; Naoko Kanatani; Reiko Nakamura; Atsuko Mizuno; Akira Zanma; Kazuki Yano; Hisataka Yasuda; Kanji Higashio; Kenji Takada; Toshihisa Komori
Journal:  J Biol Chem       Date:  2003-04-15       Impact factor: 5.157

10.  Runx2 deficiency in chondrocytes causes adipogenic changes in vitro.

Authors:  Hirayuki Enomoto; Tatsuya Furuichi; Akira Zanma; Kei Yamana; Carolina Yoshida; Satoru Sumitani; Hiroyasu Yamamoto; Motomi Enomoto-Iwamoto; Masahiro Iwamoto; Toshihisa Komori
Journal:  J Cell Sci       Date:  2004-01-26       Impact factor: 5.285

View more
  11 in total

Review 1.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

2.  Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells.

Authors:  S K Baniwal; P K Shah; Y Shi; J H Haduong; Y A Declerck; Y Gabet; B Frenkel
Journal:  Osteoporos Int       Date:  2011-09-01       Impact factor: 4.507

Review 3.  Transcriptional control of chondrocyte specification and differentiation.

Authors:  Chia-Feng Liu; William E Samsa; Guang Zhou; Véronique Lefebvre
Journal:  Semin Cell Dev Biol       Date:  2016-10-19       Impact factor: 7.727

Review 4.  Suture Cells in a Mechanical Stretching Niche: Critical Contributors to Trans-sutural Distraction Osteogenesis.

Authors:  Wei Liang; Enzhe Zhao; Guan Li; Hongsen Bi; Zhenmin Zhao
Journal:  Calcif Tissue Int       Date:  2021-11-21       Impact factor: 4.333

5.  T-cell factor 7L2 is a novel regulator of osteoblast functions that acts in part by modulation of hypoxia signaling.

Authors:  Subburaman Mohan; Chandrasekhar Kesavan
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-04-25       Impact factor: 5.900

6.  The type 2 diabetes associated rs7903146 T allele within TCF7L2 is significantly under-represented in Hereditary Multiple Exostoses: insights into pathogenesis.

Authors:  Federica Sgariglia; Elena Pedrini; Jonathan P Bradfield; Tricia R Bhatti; Pio D'Adamo; John P Dormans; Aruni T Gunawardena; Hakon Hakonarson; Jacqueline T Hecht; Luca Sangiorgi; Maurizio Pacifici; Motomi Enomoto-Iwamoto; Struan F A Grant
Journal:  Bone       Date:  2014-12-09       Impact factor: 4.398

Review 7.  Wnt and the Wnt signaling pathway in bone development and disease.

Authors:  Yiping Wang; Yi-Ping Li; Christie Paulson; Jian-Zhong Shao; Xiaoling Zhang; Mengrui Wu; Wei Chen
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

8.  An immunohistochemistry study of Sox9, Runx2, and Osterix expression in the mandibular cartilages of newborn mouse.

Authors:  Hong Zhang; Xiaopeng Zhao; Zhiguang Zhang; Weiwei Chen; Xinli Zhang
Journal:  Biomed Res Int       Date:  2013-05-16       Impact factor: 3.411

Review 9.  Role of TCF/LEF Transcription Factors in Bone Development and Osteogenesis.

Authors:  Zhengqiang Li; Zhimin Xu; Congcong Duan; Weiwei Liu; Jingchun Sun; Bing Han
Journal:  Int J Med Sci       Date:  2018-09-07       Impact factor: 3.738

Review 10.  Complex Interplay between the RUNX Transcription Factors and Wnt/β-Catenin Pathway in Cancer: A Tango in the Night.

Authors:  Kerri Sweeney; Ewan R Cameron; Karen Blyth
Journal:  Mol Cells       Date:  2020-02-29       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.